SymBio Pharmaceuticals Limited [4582.T]
TOKYO, Mar 27 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) decided today to exercise an early call option on its 66th tranche warrant issued to EVO FUND. The warrant was issued on August 12, 2025, and involves 20,000,000 shares.
The early exercise instruction was made based on a buyback agreement between the company and EVO FUND. The exercise will take effect , with the exercise period beginning on March 30, 2026.
🟡 Confidence: Standard AI-translated content.